Drug Approval | September 06, 2021
Accutest enables NMPA approval for Qilu’s Abiraterone
The bioequivalence study was conducted by Accutest Research India, one of the preferred CRO players in India
The bioequivalence study was conducted by Accutest Research India, one of the preferred CRO players in India
At present 18 per cent of the local pharmaceutical market is under government's price control
Key trends indicate that AI-based solutions, cloud-based healthcare solutions and digital transformations will be the key in the years to come.
This is the third acquisition by Healthium this year apart from AbGel business in India and VitalCare in the UK
Results reinforce the well-established safety profile of Dupixent - the first-ever biologic medicine for atopic dermatitis currently approved for patients as young 6 years old
This is Enzene Biosciences third biosimilar to be approved
The product will be available in 500 mg/2.5 mL and 1 g/5 mL vials
The company recently raised US $ 2.25 million seed round and the app was CE-Certified as a medical device in Europe
Trillium’s portfolio includes biologics that are designed to enhance the ability of patients’ innate immune system to detect and destroy cancer cells
The acquisition expands the company’s service portfolio in the transition care segment
Subscribe To Our Newsletter & Stay Updated
